Press Release: The EU-PEARL project aims to shape future drug development through a systematic approach that enables patient focused, cross company collaborative platform trials
Press Release – 18/12/19
Press Release – 18/12/19
It is now possible to subscribe to the TBMED (A testing bed for the development of high-risk medical devices) project newsletter. To do so, please click here.
Five years after its establishment, ECRIN-ERIC underwent in 2019 an external and independent scientific evaluation carried-out by ERIEC, an international consortium of research evaluation agencies.
ICPerMed's third 'Best Practice in Personalised Medicine' Recognition 2020 will honour, encourage, promote and disseminate outstanding best practice examples in personalised medicine.
The EU-PEARL (EU Patient-cEntric clinicAl tRial pLatform) project is holding its kick-off meeting from 21 to 22 November 2019 in Brussels.
The Preliminary Announcement of the European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call (JTC) 2020 is online.
The topic is: PRE-CLINICAL RESEARCH TO DEVELOP EFFECTIVE THERAPIES FOR RARE DISEASES.
The Clinical Trials Methodology Demonstration Projects Call of the European Joint Programme on Rare Diseases (EJP RD) project is now open.
Please note that this call is open only for teams from institutions that are beneficiaries of the EJP RD project.
14 November 2019 – The ICPerMed State of the Art Report 2018 has now been published.
ECRIN is pleased to announce that a new article has been published in The Lancet Gastroenterology & Hepatology entitled 'Safety of two different doses of simvastatin plus rifaximin in decomp
The RItrain project will be holding a workshop for the research infrastructure (RI) community from 20 to 21 November 2019 in Brussels, Belgium.
The Executive Masters in Management of Research Infrastructures (EMMRI) is now taking applications for the third edition, which will start in March 2020.
The European Joint Programme on Rare Diseases (EJP-RD) project has just launched an online Support Office.
ICPerMed has developed a vision of how the use of personalised medicine approaches will promote 'next-generation' medicine in 2030, more firmly centred on the individual’s personal characteristics, leading to increased effectiveness, economic value, and equitable access for all citizens to the be
A new paper has been published in the International Journal of Bipolar Disorders entitled 'Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview
Dr. Donato Bonifazi
The first EULAC-PerMed project newsletter has now been published.
ECRIN is holding its annual internal Summer School from 11 to 13 September 2019 in Balatonfüred, Hungary.